Cognitive Dysfunction

• 

  Subject Areas on Research

  • 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. 
  • A Coordinated Multi-study Analysis of the Longitudinal Association Between Handgrip Strength and Cognitive Function in Older Adults. 
  • A Geriatrics Perspective on Dementia Prevention and Treatment. 
  • A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks. 
  • A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration. 
  • A Plague on Both Your Monitors! Are Bispectral Index and Cerebral Oximetry Useful for Reducing Postoperative Cognitive Impairment? 
  • A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association. 
  • A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction. 
  • A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia. 
  • A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data. 
  • A δ Homolog for Dementia Case Finding with Replication in the Alzheimer's Disease Neuroimaging Initiative. 
  • APOE ε4 Modifies Effect of Residential Greenness on Cognitive Function among Older Adults: A Longitudinal Analysis in China. 
  • Abdominal aortic calcification and cognitive function among older adults: Cross-sectional analysis of National Health and Nutrition Examination Survey, 2013-2014. 
  • Ability of Older Adults to Report Elder Abuse: An Emergency Department-Based Cross-Sectional Study. 
  • Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms. 
  • Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US. 
  • Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials. 
  • Alterations in metabolic pathways and networks in Alzheimer's disease. 
  • Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome. 
  • Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers. 
  • American Geriatrics Society and National Institute on Aging Bench-to-Bedside Conference: Sensory Impairment and Cognitive Decline in Older Adults. 
  • American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Delirium Prevention. 
  • Amnestic mild cognitive impairment and incident dementia and Alzheimer's disease in geriatric depression. 
  • Amyloid beta-positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity. 
  • Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. 
  • An assessment by the Statin Cognitive Safety Task Force: 2014 update. 
  • Analysis of pleiotropic genetic effects on cognitive impairment, systemic inflammation, and plasma lipids in the Health and Retirement Study. 
  • Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV. 
  • Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. 
  • Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. 
  • Application of neuropsychological criteria to classify mild cognitive impairment in the active study. 
  • Art Attendance and Change in Cognitive Function Among U.S. Community-Dwelling Chinese Older Adults. 
  • Assessment of Dentally Related Function in Individuals with Cognitive Impairment: The Dental Activities Test. 
  • Assessment of Instrumental Activities of Daily Living in Older Adults with Subjective Cognitive Decline Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT). 
  • Association Between Blood Pressure Variability With Dementia and Cognitive Impairment: A Systematic Review and Meta-Analysis. 
  • Association Between Blood Pressure and Later-Life Cognition Among Black and White Individuals. 
  • Association Between Late-Life Blood Pressure and the Incidence of Cognitive Impairment: A Community-Based Prospective Cohort Study. 
  • Association Between Neurocognitive Decline and Visual Field Variability in Glaucoma. 
  • Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease. 
  • Association between diabetic retinopathy and incident cognitive impairment. 
  • Association between indoor ventilation frequency and cognitive function among community-dwelling older adults in China: results from the Chinese longitudinal healthy longevity survey. 
  • Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancer. 
  • Association between the self-reported duration and quality of sleep and cognitive function among middle-aged and older adults in China. 
  • Association between tooth loss and cognitive decline: A 13-year longitudinal study of Chinese older adults. 
  • Association between tooth loss and cognitive function among 3063 Chinese older adults: a community-based study. 
  • Association between vision impairment and cognitive decline in older adults with stroke: Health and Retirement Study. 
  • Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study. 
  • Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers. 
  • Association of CSF CD40 levels and synaptic degeneration across the Alzheimer's disease spectrum. 
  • Association of Cognitive Impairment With Treatment and Outcomes in Older Myocardial Infarction Patients: A Report From the NCDR Chest Pain-MI Registry. 
  • Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression. 
  • Association of Nondisease-Specific Problems with Mortality, Long-Term Care, and Functional Impairment among Older Adults Who Require Skilled Nursing Care after Dialysis Initiation. 
  • Association of Open-Angle Glaucoma with Non-Alzheimer's Dementia and Cognitive Impairment. 
  • Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease. 
  • Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults. 
  • Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults. 
  • Association of cognitive impairment and elderly mortality: differences between two cohorts ascertained 6-years apart in China. 
  • Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. 
  • Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study. 
  • Association of neuropsychiatric symptoms and sub-syndromes with cognitive impairment in community-dwelling Asian elderly. 
  • Association of silent lacunar infarct with brain atrophy and cognitive impairment. 
  • Associations of Sarcopenia, Handgrip Strength and Calf Circumference with Cognitive Impairment among Chinese Older Adults. 
  • Atomic connectomics signatures for characterization and differentiation of mild cognitive impairment. 
  • Baseline Cognitive Performance and Treatment Outcomes From Cognitive-Behavioral Therapies for Posttraumatic Stress Disorder: A Naturalistic Study. 
  • Basic auditory processing deficits and their association with auditory emotion recognition in schizophrenia. 
  • Bayesian inference and dynamic prediction of multivariate joint model with functional data: An application to Alzheimer's disease. 
  • Beyond Thiamine: Treatment for Cognitive Impairment in Korsakoff's Syndrome. 
  • Blue Genes, Exercise, and Cognition in Late-Life Depression: A Lot of Moving Parts. 
  • Brain PET in the diagnosis of Alzheimer's disease. 
  • Brain atrophy rates in first degree relatives at risk for Alzheimer's. 
  • Brain network functional connectivity and cognitive performance in major depressive disorder. 
  • Brain-age in midlife is associated with accelerated biological aging and cognitive decline in a longitudinal birth cohort. 
  • Bridging silos: Taking a page from the Alzheimer playbook. 
  • Building research in diet and cognition: The BRIDGE randomized controlled trial. 
  • CAP--advancing the evaluation of preclinical Alzheimer disease treatments. 
  • CSF biomarker changes precede symptom onset of mild cognitive impairment. 
  • Can Addressing Personality Change Enhance Cognitive Functioning and Delay Development of Mild Cognitive Impairment? 
  • Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group. 
  • Cardiac Rehabilitation in Older Adults with Heart Failure: Fitting a Square Peg in a Round Hole. 
  • Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease. 
  • Care partner-assisted intervention to improve oral health for older adults with cognitive impairment: A feasibility study. 
  • Caregiver-Reported Sleep Disturbances Are Associated With Behavioral and Psychological Symptoms in an Asian Elderly Cohort With Cognitive Impairment-No Dementia. 
  • Caregivers in China: knowledge of mild cognitive impairment. 
  • Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features. 
  • Challenges in measuring the effects of pharmacological interventions on cognitive and adaptive functioning in individuals with Down syndrome: A systematic review. 
  • Change of Cognitive Function in U.S. Chinese Older Adults: A Population-Based Study. 
  • Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease. 
  • Characteristics of neurocognitive functions in mild cognitive impairment with depression. 
  • Characterization of bilateral frontal lobe cerebral oxygen saturation in patients with mild traumatic brain injury. 
  • Chemotherapy-related cognitive impairment in older patients with cancer. 
  • Choroidal Structural Analysis in Alzheimer Disease, Mild Cognitive Impairment, and Cognitively Healthy Controls. 
  • Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau. 
  • Classifying neurocognitive disorders: the DSM-5 approach. 
  • Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder. 
  • Clinical outcomes of older depressed patients with and without comorbid neuroticism. 
  • Cognition, Physical Function, and Quality of Life in Older Patients With Acute Decompensated Heart Failure. 
  • Cognitive Decline and Disrupted Cognitive Trajectory in Schizophrenia. 
  • Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial. 
  • Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke? 
  • Cognitive Impairment among People Who Use Heroin and Fentanyl: Findings from the Miami Adult Studies on HIV (MASH) Cohort. 
  • Cognitive Impairment among Veterans in Outpatient Vision Rehabilitation. 
  • Cognitive Subtyping in Schizophrenia: A Latent Profile Analysis. 
  • Cognitive decline and mortality among community-dwelling Chinese older people. 
  • Cognitive function prior to systemic therapy and subsequent well-being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study. 
  • Cognitive impairment and all-cause mortality among Chinese adults aged 80 years or older. 
  • Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation. 
  • Cognitive performance in antidepressant-free recurrent major depressive disorder. 
  • Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue. 
  • Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial. 
  • Cognitive variability, brain aging, and cognitive decline in late-life major depression. 
  • Cognitively Intact and Happy Life Expectancy in the United States. 
  • Commentary: A Neurosurgeon's Guide to Cognitive Dysfunction in Adult Glioma. 
  • Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study. 
  • Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy. 
  • Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS). 
  • Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease. 
  • Connectome-scale assessments of structural and functional connectivity in MCI. 
  • Constrained sparse functional connectivity networks for MCI classification. 
  • Correlation of OCTA and Volumetric MRI in Mild Cognitive Impairment and Alzheimer's Disease. 
  • Cortical iron mediates age-related decline in fluid cognition. 
  • Cortical thickness predicts remission of depression with antidepressants in patients with late-life depression and cognitive impairment. 
  • Corticolimbic brain anomalies are associated with cognitive subtypes in psychosis: A longitudinal study. 
  • Cross-cultural adaptation and psychometric properties of the MMSE and MoCA questionnaires in Tanzanian Swahili for a traumatic brain injury population. 
  • Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers. 
  • Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial. 
  • Depressive symptoms and mild cognitive impairment in the elderly: an ominous combination. 
  • Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. 
  • Development and Validation of a Nomogram for Predicting the 6-Year Risk of Cognitive Impairment Among Chinese Older Adults. 
  • Development of a protocol to assess within-subject, regional white matter hyperintensity changes in aging and dementia. 
  • Development of an UPSA Short Form for Use in Longitudinal Studies in the Early Alzheimer's Disease Spectrum. 
  • Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease. 
  • Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial. 
  • Dose-Response Meta-Analysis on Tooth Loss With the Risk of Cognitive Impairment and Dementia. 
  • Drivers of Long-Term Care Considerations by Persons With Cognitive Impairment. 
  • Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting. 
  • Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. 
  • Edentulism and Trajectories of Cognitive Functioning Among Older Adults: The Role of Dental Care Service Utilization. 
  • Editorial Comment: Is It Time to Take the "Sub" Out of Subsyndromal Depression? 
  • Educational attainment and hippocampal atrophy in the Alzheimer's disease neuroimaging initiative cohort. 
  • Effectiveness of Florbetapir PET Imaging in Changing Patient Management. 
  • Effectiveness of a Personalized Brain-Computer Interface System for Cognitive Training in Healthy Elderly: A Randomized Controlled Trial. 
  • Effects and mediating mechanisms of a structured limbs-exercise program on general cognitive function in older adults with mild cognitive impairment: A randomized controlled trial. 
  • Effects of early life stress on depression, cognitive performance and brain morphology. 
  • Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study. 
  • Elevated brain lesion volumes in older adults who use calcium supplements: a cross-sectional clinical observational study. 
  • Evaluating Alzheimer Disease With Flortaucipir and Florbetapir PET: A Clinical Case Series. 
  • Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI. 
  • Evaluation and Management of Autoimmune Encephalitis: A Clinical Overview for the Practicing Child Psychiatrist. 
  • Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma. 
  • Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. 
  • Event-related functional magnetic resonance imaging changes during relational retrieval in normal aging and amnestic mild cognitive impairment. 
  • Financial Management Skills in Aging, MCI and Dementia: Cross Sectional Relationship to 18F-Florbetapir PET Cortical β-amyloid Deposition. 
  • Fine-granularity functional interaction signatures for characterization of brain conditions. 
  • Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. 
  • Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. 
  • Food Insecurity and Cognitive Impairment in the Miami Adult Studies on HIV (MASH) Cohort. 
  • Frailty Among Older Decompensated Heart Failure Patients: Prevalence, Association With Patient-Centered Outcomes, and Efficient Detection Methods. 
  • Functional decline in older adults. 
  • Functional limitations in older adults who have cognitive impairment without dementia. 
  • Functional signature of conversion of patients with mild cognitive impairment. 
  • Gender differences in the association between migration and cognitive function among older adults in China and India. 
  • General Behavioral Engagement and Changes in Clinical and Cognitive Outcomes of Patients with Type 2 Diabetes Using the Time2Focus Mobile App for Diabetes Education: Pilot Evaluation. 
  • General anesthetic and the risk of dementia in elderly patients: current insights. 
  • Generation and quality control of lipidomics data for the alzheimer's disease neuroimaging initiative cohort. 
  • Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. 
  • Geriatric Assessment of Physical and Cognitive Functioning in a Diverse Cohort of Systemic Lupus Erythematosus Patients: A Pilot Study. 
  • Group-constrained sparse fMRI connectivity modeling for mild cognitive impairment identification. 
  • Hearing Loss: The Silent Risk for Psychiatric Disorders in Late Life. 
  • Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's disease. 
  • Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration. 
  • How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment? 
  • Human immunodeficiency virus-related decreases in corpus callosal integrity and corresponding increases in functional connectivity. 
  • Hypogyrification and its association with cognitive impairment in children with 22q11.2 deletion Syndrome: A preliminary report. 
  • Identification of MCI individuals using structural and functional connectivity networks. 
  • Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer's disease. 
  • Identification of mild cognitive impairment in ACTIVE: algorithmic classification and stability. 
  • Identifying treatment effects of an informal caregiver education intervention to increase days in the community and decrease caregiver distress: a machine-learning secondary analysis of subgroup effects in the HI-FIVES randomized clinical trial. 
  • Immune function, cortisol, and cognitive decline & dementia in an aging latino population. 
  • Impact of COVID-19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research. 
  • Impact of Cognitive Impairment Across Specialties: Summary of a Report From the U13 Conference Series. 
  • Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders. 
  • Impact of ¹⁸F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making. 
  • Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. 
  • Independent Association Between Preoperative Cognitive Status and Discharge Location After Surgery: A Strategy to Reduce Resource Use After Surgery for Deformity. 
  • Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer. 
  • Innovation in care for individuals with cognitive impairment: Can reimbursement policy spread best practices? 
  • Interaction between APOE ε4 and dietary protein intake on cognitive decline: A longitudinal cohort study. 
  • Interaction of greenness and polygenic risk score of Alzheimer's disease on risk of cognitive impairment. 
  • International drive to illuminate delirium: A developing public health blueprint for action. 
  • Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms. 
  • Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot study. 
  • Investigating Predictors of Cognitive Decline Using Machine Learning. 
  • Language processing in age-related macular degeneration associated with unique functional connectivity signatures in the right hemisphere. 
  • Late-Life Cognitive Trajectories and their Associated Lifestyle Factors. 
  • Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction. 
  • Leisure activities, education, and cognitive impairment in Chinese older adults: a population-based longitudinal study. 
  • Lest we forget: comparing retrospective and prospective assessments of adverse childhood experiences in the prediction of adult health. 
  • Lifestyle and Neurocognition in Older Adults With Cardiovascular Risk Factors and Cognitive Impairment. 
  • Living With Cognitive Impairment in China: Exploring Dyadic Experiences Through a Person-Centered Care Lens. 
  • Long-Term Blood Pressure Level and Variability From Midlife to Later Life and Subsequent Cognitive Change: The ARIC Neurocognitive Study. 
  • Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study). 
  • Long-Term Cognitive Deficits After Subarachnoid Hemorrhage in Rats. 
  • Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers. 
  • Long-term chemogenetic activation of M1 glutamatergic neurons attenuates the behavioral and cognitive deficits caused by intracerebral hemorrhage. 
  • Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. 
  • Longitudinal Association Between Hearing Loss, Vision Loss, Dual Sensory Loss, and Cognitive Decline. 
  • Longitudinal Associations of US Acculturation With Cognitive Performance, Cognitive Impairment, and Dementia. 
  • Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis. 
  • Longitudinal Cognitive Outcomes of Clinical Phenotypes of Late-Life Depression. 
  • Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients. 
  • Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease. 
  • Lowering the Floor on Trail Making Test Part B: Psychometric Evidence for a New Scoring Metric. 
  • MAPT rs242557 variant is associated with hippocampus tau uptake on 18F-AV-1451 PET in non-demented elders. 
  • MRI Clinical Ratings and Cognitive Function in a Cross-Sectional Population Study of Dementia: The Cache County Memory Study. 
  • Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth. 
  • Measurement Properties of the CAPACITY Instrument to Assess Perceived Communication With the Health Care Team Among Care Partners of Patients With Cognitive Impairment. 
  • Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors. 
  • Measuring and Intervening to Instill Purpose in Life for Older Adults to Prevent Cognitive Decline. 
  • Memory Impairment in HIV-Infected Individuals with Early and Late Initiation of Regular Marijuana Use. 
  • Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease. 
  • Metabolic and Neurocognitive Changes Following Lifestyle Modification: Examination of Biomarkers from the ENLIGHTEN Randomized Clinical Trial. 
  • Metabolic network failures in Alzheimer's disease: A biochemical road map. 
  • Microvascular Endothelial Function and Neurocognition Among Adults With Major Depressive Disorder. 
  • Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes. 
  • Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice. 
  • Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images. 
  • Multivariate MR biomarkers better predict cognitive dysfunction in mouse models of Alzheimer's disease. 
  • Neighborhoods, sleep quality, and cognitive decline: Does where you live and how well you sleep matter? 
  • Neural sensitivity to risk in adults with co-occurring HIV infection and cocaine use disorder. 
  • Neurocognitive Function after Cardiac Surgery: From Phenotypes to Mechanisms. 
  • Neurocognitive disorders in DSM-5. 
  • Neurocognitive markers of childhood abuse in individuals with PTSD: Findings from the INTRuST Clinical Consortium. 
  • Neurodevelopmental Impairment Among Extremely Preterm Infants in the Neonatal Research Network. 
  • Neuroinflammation and Perioperative Neurocognitive Disorders. 
  • Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease. 
  • Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. 
  • Neuroticism Traits Selectively Impact Long Term Illness Course and Cognitive Decline in Late-Life Depression. 
  • Neurotransmitter Pathway Genes in Cognitive Decline During Aging: Evidence for GNG4 and KCNQ2 Genes. 
  • New applications of disease genetics and pharmacogenetics to drug development. 
  • Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. 
  • Nurses' concerns about caring for patients with acute and chronic traumatic brain injury. 
  • Oral Health Symptoms and Cognitive Function Among US Community-Dwelling Chinese Older Adults. 
  • Orthopedic Surgery Triggers Attention Deficits in a Delirium-Like Mouse Model. 
  • Orthopedic surgery modulates neuropeptides and BDNF expression at the spinal and hippocampal levels. 
  • Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis. 
  • Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease. 
  • Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review. 
  • Perioperative neurocognitive and functional neuroimaging trajectories in older APOE4 carriers compared with non-carriers: secondary analysis of a prospective cohort study. 
  • Person-Centered Incontinence Care in Residential Care Facilities for Older Adults With Cognitive Decline: Feasibility and Preliminary Effects on Quality of Life and Quality of Care. 
  • Perspectives on Deprescribing Communication in Primary Care. 
  • Pharmacist Identification of Medication Therapy Problems Involving Cognition Among Older Adults Followed by a Home-Based Care Team. 
  • Pharmacological interventions to improve cognition and adaptive functioning in Down syndrome: Strides to date. 
  • Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease. 
  • Physical exercise increases involvement of motor networks as a compensatory mechanism during a cognitively challenging task. 
  • Plasma Amyloid Beta Concentrations in Aged and Cognitively Impaired Pet Dogs. 
  • Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease. 
  • Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia. 
  • Postoperative Delirium and Postoperative Cognitive Dysfunction: Two Sides of the Same Coin? 
  • Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach. 
  • Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data. 
  • Predictive Utility of Marketed Volumetric Software Tools in Subjects at Risk for Alzheimer Disease: Do Regions Outside the Hippocampus Matter? 
  • Predictive models of resting state networks for assessment of altered functional connectivity in mild cognitive impairment. 
  • Predictors of Ventriculoperitoneal Shunt Revision in Patients with Idiopathic Normal Pressure Hydrocephalus. 
  • Prefrontal contributions to relational encoding in amnestic mild cognitive impairment. 
  • Preoperative Cognitive Impairment As a Predictor of Postoperative Outcomes in a Collaborative Care Model. 
  • Prevalence of Alzheimer's pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives. 
  • Prevalence of Cognitive Impairment and Dementia in Malays - Epidemiology of Dementia in Singapore Study. 
  • Prevalence of cognitive impairment in Chinese: epidemiology of dementia in Singapore study. 
  • Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. 
  • Preventing Cognitive Decline. 
  • Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data. 
  • Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study. 
  • Protocol for a feasibility randomised controlled trial of Screening and Enhanced Risk management for Vascular Event-related Decline in Memory (SERVED Memory). 
  • Quantification of the pace of biological aging in humans through a blood test, the DunedinPoAm DNA methylation algorithm. 
  • RESEARCHCognition and Capacity to Consent for Elective Surgery. 
  • Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies. 
  • Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. 
  • Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. 
  • Recruitment of a multi-site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial. 
  • Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study. 
  • Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease. 
  • Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease. 
  • Reply to: "Comment on Choroidal Structural Analysis in Alzheimer Disease, Mild Cognitive Impairment, and Cognitively Healthy Controls". 
  • Response to Bora. 
  • Resting-State Functional Connectivity and Cognition After Major Cardiac Surgery in Older Adults without Preoperative Cognitive Impairment: Preliminary Findings. 
  • Resting-state multi-spectrum functional connectivity networks for identification of MCI patients. 
  • Retinal Microvascular and Neurodegenerative Changes in Alzheimer's Disease and Mild Cognitive Impairment Compared with Control Participants. 
  • Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease. 
  • Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease. 
  • Reversible Dementias. 
  • Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. 
  • Self-Reported Cognitive Impairment Across Racial/Ethnic Groups in the United States, National Health Interview Survey, 1997-2015. 
  • Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease. 
  • Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment. 
  • Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification. 
  • Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers. 
  • Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer's disease. 
  • Short-Term Changes in the Prevalence of Probable Dementia: An Analysis of the 2011-2015 National Health and Aging Trends Study. 
  • Slower information processing speed is associated with persistent burnout symptoms but not depression symptoms in nursing workers. 
  • Social Support, Social Strain, and Cognitive Function Among Community-Dwelling U.S. Chinese Older Adults. 
  • Society of Critical Care Medicine's International Consensus Conference on Prediction and Identification of Long-Term Impairments After Critical Illness. 
  • Something Is Better Than Nothing: The Value of Active Intervention in Stated Preferences for Treatments to Delay Onset of Alzheimer's Disease Symptoms. 
  • Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment. 
  • Specific Leisure Activities and Cognitive Functions Among the Oldest-Old: The Chinese Longitudinal Healthy Longevity Survey. 
  • Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis. 
  • Strategies nurses use when caring for patients with moderate-to-severe traumatic brain injury who have cognitive impairments. 
  • Subjective cognitive impairment and quality of life: a systematic review. 
  • Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study. 
  • TOMM40'523 variant and cognitive decline in older persons with APOE ε3/3 genotype. 
  • TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks. 
  • Targeted metabolomics and medication classification data from participants in the ADNI1 cohort. 
  • Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin. 
  • Targeting microglia to mitigate perioperative neurocognitive disorders. 
  • Task-related changes in degree centrality and local coherence of the posterior cingulate cortex after major cardiac surgery in older adults. 
  • Technology-based cognitive training and rehabilitation interventions for individuals with mild cognitive impairment: a systematic review. 
  • The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice. 
  • The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI. 
  • The Association Between Mild Cognitive Impairment Diagnosis and Patient Treatment Preferences: a Survey of Older Adults. 
  • The Association Between Retinal Neuronal Layer and Brain Structure is Disrupted in Patients with Cognitive Impairment and Alzheimer's Disease. 
  • The Association Between Toxic Exposures and Chronic Multisymptom Illness in Veterans of the Wars of Iraq and Afghanistan. 
  • The Devil Is in the Details: Comparison of Postoperative Delirium and Neurocognitive Dysfunction. 
  • The Impact of Marijuana Use on Memory in HIV-Infected Patients: A Comprehensive Review of the HIV and Marijuana Literatures. 
  • The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia. 
  • The Mind Is Your Best Muscle: TAVR/SAVR Outcomes in Patients With Cognitive Impairment. 
  • The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. 
  • The Origins of Cognitive Deficits in Victimized Children: Implications for Neuroscientists and Clinicians. 
  • The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms. 
  • The Vascular Impairment of Cognition Classification Consensus Study. 
  • The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study. 
  • The association between cognitive function and subsequent depression: a systematic review and meta-analysis. 
  • The association between neighborhood socioeconomic status, cardiovascular and cerebrovascular risk factors, and cognitive decline in the Health and Retirement Study (HRS). 
  • The broad spectrum mixed-lineage kinase 3 inhibitor URMC-099 prevents acute microgliosis and cognitive decline in a mouse model of perioperative neurocognitive disorders. 
  • The immune response of the human brain to abdominal surgery. 
  • The impact of residential status on cognitive decline among older adults in China: Results from a longitudinal study. 
  • The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment. 
  • The relationship between negative symptom subdomains and cognition. 
  • Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment. 
  • Top Ten Tips Palliative Care Clinicians Should Know About Cognitive Impairment and Institutional Care. 
  • Trajectories of Depressive Symptoms, Neurocognitive Function, and Viral Suppression With Antiretroviral Therapy Among Youth With HIV Over 36 months. 
  • Trajectories of depressive symptoms and subsequent cognitive decline in older adults: a pooled analysis of two longitudinal cohorts. 
  • Treating cognitive impairment in depression: an unmet need. 
  • Trends in functional disability and cognitive impairment among the older adult in China up to 2060: estimates from a dynamic multi-state population model. 
  • Triglycerides Paradox Among the Oldest Old: "The Lower the Better?" 
  • Two Methods for Calculating Symptom Cluster Scores. 
  • Type 2 diabetes mellitus, brain atrophy, and cognitive decline. 
  • Understanding on the association between informal caregiver characteristics and cognitive function of adults with cancer: a scoping review protocol. 
  • Urban-rural differences in the association between access to healthcare and health outcomes among older adults in China. 
  • Use of Cognitive Testing, Questionnaires, and Plasma Biomarkers to Quantify Cognitive Impairment in an Aging Pet Dog Population. 
  • Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome. 
  • Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. 
  • Using smartphone technology to improve prospective memory functioning: A randomized controlled trial. 
  • Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting. 
  • Utilizing Trigger Films to Enhance Communication Skills of Home Care Clinicians. 
  • Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia. 
  • Validity of the Web-Based, Self-Directed, NeuroCognitive Performance Test in Mild Cognitive Impairment. 
  • Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). 
  • Video-Enhanced Care Management for Medically Complex Older Adults with Cognitive Impairment. 
  • Vision impairment and cognitive decline among older adults: a systematic review. 
  • Visit-to-Visit Variability in Blood Pressure Is Related to Late-Life Cognitive Decline. 
  • Where do we cut the bell-shaped curve of CIAS? 
  • White matter in different regions evolves differently during progression to dementia. 
  • Willingness to Undergo a Risky Treatment to Improve Cognition Among Persons With Cognitive Impairment Who Received an Amyloid PET Scan. 
  • Working together to learn new oral hygiene techniques: Pilot of a carepartner-assisted intervention for persons with cognitive impairment. 
• 

  Keywords of People

  • Doraiswamy, P. Murali, Professor of Psychiatry and Behavioral Sciences, Duke Science & Society